Deutsche Bank’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Deutsche Bank’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-390,623	Closed	-$99.6K	–	4084
2023 Q1	$99.6K	Buy	390,623 +11,463	+3%	+$10.4K	﹤0.01%	3331
2022 Q4	$447K	Buy	379,160 +456	+0.1%	+$959	﹤0.01%	2505
2022 Q3	$773K	Buy	378,704 +28,704	+8%	+$48.7K	﹤0.01%	2127
2022 Q2	$539K	Buy	+350,000	New	+$1.37M	﹤0.01%	2549

Deutsche Bank's PEAR Position: Q2 2023 in Review

Deutsche Bank sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 390,623 shares — an estimated $99.6K sold.

Deutsche Bank first reported a position in PEAR in Q2 2022 and held it in 4 quarters. The position peaked at $773K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

Deutsche Bank reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Deutsche Bank sold 390,623 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $99.6K.
Deutsche Bank first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Deutsche Bank's Pear Therapeutics, Inc. Class A Common Stock position peaked at $773K in Q3 2022.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on Deutsche Bank's 13F filing for Q2 2023, filed 14 Aug 2023.